The answers to these questions will hopefully lead to a greater knowledge of the molecular mechanisms in which LDLR receptors are involved, and LRP8 in particular, to develop new diagnostic and therapeutic tools that can be used both in oncology and in some neurodegenerative conditions such as the Alzheimer’s dementia and pathologies related to aberrant neuronal migration. Here, LRP8 is linked to Alzheimer disease.